526445
INDRANIB
Invest Now
Start SIP in
INDRANIB
Performance
- Low
- ₹15
- High
- ₹16
- 52 Week Low
- ₹14
- 52 Week High
- ₹63
- Open Price₹15
- Previous Close₹15
- Volume117,241
Investment Returns
- Over 1 Month -20.55%
- Over 3 Month -28.74%
- Over 6 Month -62.5%
- Over 1 Year -69.22%
Smart Investing Starts Here Start SIP with Indrayani Biotech for Steady Growth!
Indrayani Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 11.7
- PEG Ratio
- -0.7
- Market Cap Cr
- 72
- P/B Ratio
- 1
- Average True Range
- 0.81
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.66
- RSI
- 34.05
- MFI
- 38.87
Indrayani Biotech Financials
Indrayani Biotech Technicals
EMA & SMA
Current Price
₹15.89
+
0.69
(4.54%)

-
- Bearish Moving Average 14
-
- Bullish Moving Average 2
- 20 Day
- ₹17.14
- 50 Day
- ₹19.25
- 100 Day
- ₹23.91
- 200 Day
- ₹31.95
Resistance and Support
15.47
- R3 17.80
- R2 16.88
- R1 16.39
- S1 14.98
- S2 14.06
- S3 13.57
Indrayani Biotech Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-04-03 | Rights issue of Equity Shares | |
2025-02-27 | Quarterly Results | |
2024-11-14 | Quarterly Results & Rights issue | |
2024-08-14 | Quarterly Results | |
2024-07-27 | Others | Inter alia, To fix the date, time, venue and mode of 32ndAnnual General Meeting of the Company and approve the draft Notice for convening the said General Meeting. |
Indrayani Biotech F&O
About Indrayani Biotech
- NSE Symbol
- INDRANIB
- BSE Symbol
- 526445
- Managing Director
- Mr. Kasiraman Sayee Sundar
- ISIN
- INE007C01021
Similar Stocks to Indrayani Biotech
Indrayani Biotech FAQs
Indrayani Biotech share price is ₹15 As on 17 May, 2025 | 23:51
The Market Cap of Indrayani Biotech is ₹72.4 Cr As on 17 May, 2025 | 23:51
The P/E ratio of Indrayani Biotech is 11.7 As on 17 May, 2025 | 23:51
The PB ratio of Indrayani Biotech is 1 As on 17 May, 2025 | 23:51
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.